Komori
Fuji Pharma (4554) · RiskRestated

Foreign Exchange Fluctuation Risk Associated with Raw Material Imports and Hedging with Forward Exchange Contracts

First written in FY2018. 6 of 8 entries say "Restated". Latest entry: 2026-08-06.

8entries
9years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2018RestatedFY2023-Q1 – 2026-08-062018: 12019: 020192020: 020202021: 020212022: 120222023: 320232024: 220242025: 020252026: 12026
Same theme, other companies
Rising import procurement costs due to yen depreciation and exchange-rate fluctuationsA theme 74 companies write about · 74 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2022: 33 of 58 companies on the "Worse" side.

34 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 74 companies compared. The sentences above are computed from all 74.
Full recordFilings, disclosures and news, newest first
  1. 2026-08-06RestatedEarnings

    「The trend toward yen depreciation continued amid soaring raw material and energy prices.」

    The company continues to cite foreign exchange and cost conditions related to imported raw materials as sources of uncertainty.
  2. FY2024-Q2RestatedAnnual report

    「During the second quarter of the fiscal year under review, Japan's economy continued to face unstable global conditions, soaring raw material and energy prices, and a weakening trend in the yen.」

    Continues to describe the foreign exchange and cost environment of surging raw material and energy prices and continued yen depreciation.
  3. FY2024-Q1RestatedAnnual report

    「During the first quarter of the fiscal year under review, Japan's domestic economic outlook became uncertain as unstable global conditions continued, raw material and energy prices soared, the yen continued to weaken and prices continued to rise.」

    Continues to describe the external environment of surging raw material and energy prices and continued yen depreciation as environmental factors related to foreign exchange risk.
  4. FY2023-Q3RestatedAnnual report

    「During the third quarter of the fiscal year under review, Japan's economy began to show signs of recovery, particularly in private consumption, as efforts to balance COVID-19 measures with economic activity progressed. However, amid continuing instability in global conditions, soaring raw material and energy prices, and sharp exchange-rate fluctuations, prices continued to rise, leaving the outlook uncertain.」

    Continues to describe the uncertain outlook caused by surging raw material and energy prices and sharp foreign exchange fluctuations.
  5. FY2023-Q2RestatedAnnual report

    「During the second quarter of the fiscal year under review, Japan's economy began to show signs of recovery, particularly in private consumption, as efforts to balance COVID-19 measures with economic activity progressed. However, amid continuing instability in global conditions, soaring raw material and energy prices, and sharp exchange-rate fluctuations, prices continued to rise, leaving the outlook uncertain.」

    Continues to describe the uncertain outlook caused by surging raw material and energy prices and sharp foreign exchange fluctuations.
  6. FY2023-Q1RestatedAnnual report

    「During the first quarter of the fiscal year under review, Japan's economy began to show signs of recovery, particularly in private consumption, as efforts to balance COVID-19 measures with economic activity progressed. However, amid continuing instability in global conditions, soaring raw material and energy prices, and sharp exchange-rate fluctuations, prices continued to rise, leaving the outlook uncertain.」

    Although the wording has changed from the previous fiscal year’s “rapid yen depreciation” to “sharp foreign exchange fluctuations,” it continues to describe the uncertain outlook caused by foreign exchange movements.
  7. FY2022WorsenedAnnual report

    「During the fiscal year under review, amid the continued spread of COVID-19, raw material and energy prices rose and the yen depreciated sharply following the start of Russia's military invasion of Ukraine, among other factors. As prices began to increase, conditions both in Japan and overseas became uncertain and unpredictable.」

    In connection with foreign exchange risk associated with raw material imports and other transactions, describes rapid yen depreciation as a change in the external environment.
  8. FY2018First statedAnnual report

    「Certain foreign-currency-denominated accounts payable are exposed to foreign exchange risk, but as a general rule we hedge this risk using forward exchange contracts.」

    For the first time, creates a thread on the foreign exchange risk associated with foreign-currency-denominated accounts payable arising from raw material imports and other transactions, and the policy of hedging with forward exchange contracts.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Fuji Pharma yet. It last moved in the Earnings of 2026-08-06: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Foreign Exchange Fluctuation Risk Associated with Raw Material Imports and Hedging with Forward Exchange Contracts | Fuji Pharma Co.,Ltd. (4554) | Komori